Results 191 to 200 of about 131,241 (336)

Analysis of Complications in Patients Receiving Adjuvant Irradiation for Endometrial Carcinoma

open access: bronze, 1990
K.M. Greven   +3 more
openalex   +1 more source

Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR‐SCREEN‐2 Study

open access: yesCancer Science, EarlyView.
ABSTRACT Claudin 18.2 (CLDN18.2), a tight junction protein isoform, is an emerging therapeutic target in oncology. CLDN18 is well‐characterized in gastric cancer, but its pan‐cancer expression profiles and isoform distributions are poorly documented.
Tadayoshi Hashimoto   +28 more
wiley   +1 more source

Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma. [PDF]

open access: yesJ Exp Clin Cancer Res
Hou X   +21 more
europepmc   +1 more source

Pathological stage 3 endometrial carcinoma: Prognostic significance of extrauterine sites

open access: bronze, 1992
K.M. Greven   +4 more
openalex   +1 more source

Expression of ps2 protein in endometrial carcinomas: Correlation with clinicopathologic features and sex steroid receptor status [PDF]

open access: bronze, 1997
Masafumi Koshiyama   +7 more
openalex   +1 more source

Ligand‐Based CAR‐T Cells Targeting EGFR Exhibit Favorable Antitumor Effects Against Gynecologic Malignancies

open access: yesCancer Science, EarlyView.
Wide variety of gynecologic malignancies express EGFR at high rates. Memory‐rich EGFR CAR‐T cells can be made by piggyBac‐mediated gene transfer with immature dendritic cells and EGFR protein. Ligand‐based EGFR CAR‐T cells have robust antitumor effects against gynecologic malignancies in vivo and in vitro.
Manaka Shinagawa   +16 more
wiley   +1 more source

Development and characterization of a dual-fiber Raman probe for accurate and rapid endometrial carcinoma detection. [PDF]

open access: yesBiomed Opt Express
Chen X   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy